Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 23Neoplasm Metastasis 14Neoplasms 13Rectal Neoplasms 8Colorectal Cancer Metastatic 6Ovarian Neoplasms 5Lymphoma, Non-Hodgkin 5Colonic Neoplasms 5Uveal Melanoma 4Sarcoma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Melanoma 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Lymphocytic, Chronic, B-Cell 4Fallopian Tube Neoplasms 4Carcinoma, Ovarian Epithelial 4Burkitt Lymphoma 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Urethral Neoplasms 3Stomach Neoplasms 3Prostatic Neoplasms 3Lung Neoplasms 3Glioblastoma 3Endometrial Neoplasms 3Carcinoma, Renal Cell 3

Interventions

Irinotecan 6Cyclophosphamide 4temsirolimus 2Sirolimus 2Filgrastim 2Early Intervention, Educational 2Carboplatin 2sargramostim 1reolysin 1irofulven 1cixutumumab 1aflibercept 1Vincristine 1Trabectedin 1Topotecan 1Tirapazamine 1Thiotepa 1Thalidomide 1Temozolomide 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Oxaliplatin 1Methylprednisolone 1Melphalan 1Immunologic Techniques 1Immunohistochemistry 1Gemcitabine 1Gefitinib 1Flow Cytometry 1Etoposide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Unspecified Childhood Solid Tumor, Protocol Specific × aflibercept × Clear all
NCT00622414 2014-02-24

Aflibercept in Treating Young Patients With Relapsed or Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
27 enrolled
Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡